PD-1 and PD-L1 Expression in Male Breast Cancer in Comparison with Female Breast Cancer

BACKGROUND: Male breast cancer is rare, as it represents less than 1% of all breast cancer cases. In addition, male breast cancer appears to have a different biology than female breast cancer. Programmed death-1 (PD-1) and its ligand, programmed death-ligand 1 (PD-L1), seem to have prognostic and pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Manson, Quirine F., ter Hoeve, Natalie D., Buerger, Horst, Moelans, Cathy B., van Diest, Paul J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297201/
https://www.ncbi.nlm.nih.gov/pubmed/30519815
http://dx.doi.org/10.1007/s11523-018-0610-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6297201/
https://www.ncbi.nlm.nih.gov/pubmed/30519815
http://dx.doi.org/10.1007/s11523-018-0610-1

Ejemplares similares